BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 34091443)

  • 1. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
    Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
    Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing machine learning-derived MRI-based and blood-based neurodegeneration biomarkers in predicting syndromal conversion in early AD.
    Cai Y; Fan X; Zhao L; Liu W; Luo Y; Lau AYL; Au LWC; Shi L; Lam BYK; Ko H; Mok VCT
    Alzheimers Dement; 2023 Nov; 19(11):4987-4998. PubMed ID: 37087687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
    Fan X; Cai Y; Zhao L; Liu W; Luo Y; Au LWC; Shi L; Mok VCT
    J Alzheimers Dis; 2024; 97(2):883-893. PubMed ID: 38189749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
    Zhao L; Luo Y; Lew D; Liu W; Au L; Mok V; Shi L;
    Aging (Albany NY); 2019 Aug; 11(16):6217-6236. PubMed ID: 31467257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
    Mai Y; Yu Q; Zhu F; Luo Y; Liao W; Zhao L; Xu C; Fang W; Ruan Y; Cao Z; Lei M; Au L; Mok VCT; Shi L; Liu J
    J Alzheimers Dis; 2021; 79(3):1023-1032. PubMed ID: 33459705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.
    Marizzoni M; Ferrari C; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Ribaldi F; Rossini PM; Schönknecht P; Salvatore M; Soricelli A; Hensch T; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    J Alzheimers Dis; 2019; 69(1):3-14. PubMed ID: 29914031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?
    Teipel S; Grothe MJ;
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):526-36. PubMed ID: 26555082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease.
    Dutt S; Li Y; Mather M; Nation DA;
    J Alzheimers Dis; 2020; 77(4):1579-1594. PubMed ID: 32925030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
    Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
    J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal atrophy in early Braak regions in preclinical Alzheimer's disease.
    Xie L; Wisse LEM; Das SR; Vergnet N; Dong M; Ittyerah R; de Flores R; Yushkevich PA; Wolk DA;
    Hum Brain Mapp; 2020 Nov; 41(16):4704-4717. PubMed ID: 32845545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
    Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
    Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients.
    Choo IL; Carter SF; Schöll ML; Nordberg A
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2120-6. PubMed ID: 25077930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How early can we predict Alzheimer's disease using computational anatomy?
    Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
    Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.